Ozempic may raise NAION risk, but not cause blindness directly

Ozempic side effects LEAD TO BLINDNESS?! · 5:31 · Video: Doctor Eye Health · Watch at the source

In short: Ozempic may slightly raise the risk of NAION, a rare eye condition linked to sudden vision loss, but experts say it's not a guaranteed outcome. Understanding the connection between GLP-1 drugs and NAION is key to managing risks without unnecessary alarm.

Ozempic, a GLP-1 medication used for weight loss and diabetes management, has been associated with a rare but concerning eye condition called non-arteritic anterior ischemic neuropathy (NAION). This condition, which involves reduced blood flow to the optic nerve, can lead to sudden, painless vision loss. While the risk is small, studies suggest that people using Ozempic may have an increased likelihood of developing NAION compared to those not on the medication. However, it's important to note that the findings show an association, not a direct cause-and-effect relationship. The American Academy of Ophthalmology and other medical groups have advised doctors to discuss these potential risks with patients, but they also emphasize that the benefits of Ozempic often outweigh the risks for most users.

The connection between Ozempic and NAION was highlighted in a study published in the Annals of Internal Medicine, which analyzed data from over 10,000 patients with Type 2 diabetes. The study revealed that medications such as Ozempic and Wegovy, which belong to the GLP-1 category, were connected to a slight rise in the chance of developing ischemic optic neuropathy. According to the research, roughly three to four more instances of this condition were observed for every 10,000 individuals receiving GLP-1 drugs during an 18-month period. While this risk is low, the potential for sudden vision loss has raised concerns among both patients and healthcare providers. Dr. Katherine Talcott, a vitreoretinal surgeon, explains that while there is a possible association between Ozempic and NAION, the evidence does not confirm causation. She emphasizes that most eye doctors believe the benefits of these medications outweigh the potential risks.

Despite the concerns, the medical community remains cautious about overreacting. Dr. Talcott, who co-authored a study that found no direct link between Ozempic and NAION, stresses that the condition is rare and that the majority of patients do not experience severe vision loss. In fact, about a third of those diagnosed with NAION may see some improvement in their vision over time. However, the risk is higher for certain groups, including older adults and men. The American Academy of Ophthalmology has urged medical professionals to inform patients about the possible connection, yet they advise against discontinuing the treatment without consulting a physician. The benefits of Ozempic in managing diabetes and weight often make it a valuable treatment option, even with the small risk of NAION.

Opens the Intellect+ feed with this card first. Swipe up for the next one.

Sources

To cite this card, link to https://intellectplus.co.uk/app/health-ozempic-side-effects-lead-to-blindness.

How we source, check and correct cards: Editorial standards.

General information, not professional advice. Spotted an error? Flag the card or see corrections and complaints.

Intellect Plus is a visual educational discovery platform for exploring fascinating facts and ideas. Brain Food, Not Brain Rot. What is Intellect Plus?

Related

Finding something worth knowing…